Warning letter
Dynamic Pharmaceuticals, Inc. [ARCHIVED]: warning letter of Jun 23, 2011
FDA warning letter 160893 · Florida District Office
Key facts
| Reference number | 160893 |
|---|---|
| Company | Dynamic Pharmaceuticals, Inc. [ARCHIVED] |
| Subject | Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling or Holding Operations for Dietary Supplements |
| Issue date | Jun 23, 2011 |
| Posted date | Jun 23, 2011 |
| Issuing office | Florida District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.75(c), 111.113(a)(1), 111.70, 111.70(e), 111.255(b), 111.255(c), 111, 111.260(d), 111.260(e), 111.260(j)(2), 111.320(a), 111.320(b) and 1 more |
| Inspection city | Brooksville |
| Inspection ZIP | 34604 |
| Inspection start date | Nov 22, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: